Article
Asarinin alleviates hepatic fibrosis through TRα-STAT3 pathway: A new strategy by regulating liver microenvironment
2025-03-29
Abstract excerpt
<h4>Background: </h4> and Purpose: Hepatic fibrosis is the final pathological consequence of a wide spectrum of chronic liver disease. Asarinin (ASA) has shown biological effects in various liver disorders. This study explores the hepatoprotective effects of ASA, particularly the potential mechanism. Experimental Approach: Hepatic fibrosis model was established by intraperitoneal injection of TAA in C57BL/6 mice,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- adcc17e6-3ec7-5901-bd16-c58403e99e73
- DOI
- 10.22541/au.174324107.72136341/v1
